Malaria treatment and prevention guidelines
The guidelines provide:
- evidence-based recommendations pertaining to vector control tools, technologies and approaches that are currently available for malaria prevention and control, and for which sufficient evidence on their efficacy is available to support systematic reviews. The Guidelines are intended to provide an underlying framework for the design of effective, evidence-based national vector control strategies and their adaptation to local disease epidemiology and vector bionomics;
- evidence-based recommendations on the use of antimalarial medicines as preventive chemotherapy in people living in malaria-endemic areas who are at risk of malaria morbidity and mortality. These approaches include intermittent preventive treatment (IPT) in pregnancy (IPTp), perennial malaria chemoprevention (PMC), seasonal malaria chemoprevention (SMC), intermittent preventive treatment in school aged children (IPTsc), post-discharge malaria chemoprevention (PDMC) and mass drug administration (MDA);
- evidence-based recommendation on the use of the malaria vaccine
- evidence-based recommendations on the treatment of uncomplicated and severe malaria in all age groups and situations, including in young children and pregnant women; and
- guidance on interventions in the final phase of elimination and prevention of re-establishment.